Price target
134.260.000.00%
The 10 analysts offering 1 year price forecasts for 22Z have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to 22Z in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
22Z EPS for the last quarter is −0.50 EUR despite the estimation of −0.48 EUR. In the next quarter EPS is expected to reach −0.56 EUR. Track more of ZEALAND PHARMA A/S financials and stay on top of what is up with the company.
In the next quarter ZEALAND PHARMA A/S revenue is expected to reach 8.59 M EUR. Check out ZEALAND PHARMA A/S revenue and earnings and make informed decisions.
According to analysts, 22Z price target is 134.26 EUR with a max estimate of 147.39 EUR and a min estimate of 109.20 EUR. Check if this forecast comes true in a year, meanwhile watch ZEALAND PHARMA A/S stock price chart and keep track of the current situation with 22Z news and stock market news.
We've gathered opinions of 11 analysts rating 22Z stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.